Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yufei Pan

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Molecular Therapy. Nucleic Acids|September 30, 2021
Feasibility of cRGD conjugation at 5'-antisense strand of siRNA by phosphodiester linkage extensionXinyang Zhou, Yufei Pan, Lijia Yu, et al.
Molecular Pharmaceutics|May 4, 2022
Activity and Tissue Distribution of Antisense Oligonucleotide CT102 Encapsulated with Cytidinyl/Cationic Lipid against Hepatocellular CarcinomaJing Guan, Yufei Pan, Huantong Li, et al.
Journal of Cancer Research and Clinical Oncology|November 3, 2019
Superiority of intensity-modulated radiation therapy in nasopharyngeal carcinoma with skull-base invasionShufang Liao, Yuan Xie, Yi Feng, et al.
American Journal of Otolaryngology|August 14, 2024
Effectiveness of surgery combined with photodynamic therapy for recurrent respiratory papillomatosisYufei Pan, Chao Wang, Huili Huang, et al.
Cancer|May 27, 2021
Apatinib for the treatment of metastatic or locoregionally recurrent nasopharyngeal carcinoma after failure of chemotherapy: A multicenter, single-arm, prospective phase 2 studyXiaolan Ruan, Jin-Hui Liang, Yufei Pan, et al.
Biomaterials|January 21, 2019
Structural optimization and additional targets identification of antisense oligonucleotide G3139 encapsulated in a neutral cytidinyl-lipid combined with a cationic lipid in vitro and in vivoYuan Ma, Wenting Zhao, Yiding Li, et al.
Cell Death & Disease|September 19, 2022
The therapeutic effect of KSP inhibitors in preclinical models of cholangiocarcinomaYuanyuan Shi, Xiaowen Cui, Tianyi Jiang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 26, 2021
Rational preparation and application of a mRNA delivery system with cytidinyl/cationic lipidLei Li, Jinrong Long, Ye Sang, et al.
Journal of Translational Medicine|July 2, 2024
Advancing targeted combination chemotherapy in triple negative breast cancer: nucleolin aptamer-mediated controlled drug releaseYuan Ma, Duoli Xie, Zefeng Chen, et al.
The Laryngoscope|August 29, 2024
Quantifying Bevacizumab Efficacy in Recurrent Respiratory PapillomatosisYufei Pan, Yuanyuan Lu, Huili Huang, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Molecular Therapy. Nucleic Acids|September 30, 2021
Feasibility of cRGD conjugation at 5'-antisense strand of siRNA by phosphodiester linkage extensionXinyang Zhou, Yufei Pan, Lijia Yu, et al.
Molecular Pharmaceutics|May 4, 2022
Activity and Tissue Distribution of Antisense Oligonucleotide CT102 Encapsulated with Cytidinyl/Cationic Lipid against Hepatocellular CarcinomaJing Guan, Yufei Pan, Huantong Li, et al.
Journal of Cancer Research and Clinical Oncology|November 3, 2019
Superiority of intensity-modulated radiation therapy in nasopharyngeal carcinoma with skull-base invasionShufang Liao, Yuan Xie, Yi Feng, et al.
American Journal of Otolaryngology|August 14, 2024
Effectiveness of surgery combined with photodynamic therapy for recurrent respiratory papillomatosisYufei Pan, Chao Wang, Huili Huang, et al.
Cancer|May 27, 2021
Apatinib for the treatment of metastatic or locoregionally recurrent nasopharyngeal carcinoma after failure of chemotherapy: A multicenter, single-arm, prospective phase 2 studyXiaolan Ruan, Jin-Hui Liang, Yufei Pan, et al.
Biomaterials|January 21, 2019
Structural optimization and additional targets identification of antisense oligonucleotide G3139 encapsulated in a neutral cytidinyl-lipid combined with a cationic lipid in vitro and in vivoYuan Ma, Wenting Zhao, Yiding Li, et al.
Cell Death & Disease|September 19, 2022
The therapeutic effect of KSP inhibitors in preclinical models of cholangiocarcinomaYuanyuan Shi, Xiaowen Cui, Tianyi Jiang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 26, 2021
Rational preparation and application of a mRNA delivery system with cytidinyl/cationic lipidLei Li, Jinrong Long, Ye Sang, et al.
Journal of Translational Medicine|July 2, 2024
Advancing targeted combination chemotherapy in triple negative breast cancer: nucleolin aptamer-mediated controlled drug releaseYuan Ma, Duoli Xie, Zefeng Chen, et al.
The Laryngoscope|August 29, 2024
Quantifying Bevacizumab Efficacy in Recurrent Respiratory PapillomatosisYufei Pan, Yuanyuan Lu, Huili Huang, et al.
Pageof 7